{
  "documents": [
    {
      "id": "cluster_3_doc1",
      "content": "Claim form submitted for ongoing biologic drug treatments (Cimzia) for rheumatoid arthritis management. Patient resides in Tacoma, WA with existing coverage under PlatinumPlus Plan. Initial authorization granted for 6-month duration pending quarterly reviews. Coordination between rheumatology dept at Tacoma General and outpatient infusion center noted.",
      "metadata": {
        "format": "claim_form"
      }
    },
    {
      "id": "cluster_3_doc2",
      "content": "Medical records show rheumatoid arthritis diagnosis confirmed 11/2022 after failed methotrexate trial. Patient demographics: 48yo freelance graphic designer with history of moderate disease progression. Chart notes indicate preference for self-administered meds due to irregular work schedule. Recent labs show improved CRP levels.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_3_doc3",
      "content": "Internal memo regarding 2023-11 SupremeDrug Co policy changes: Biologic medications now require prior genetic testing for all Northwest region patients. Grandfathering applies to existing auths until renewal. Impacts ~15% of RA patients in Pierce County. Implementation deadline 02/2024.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_3_doc4",
      "content": "Provider report from Tacoma Arthritis Center details treatment escalation path: NSAIDs → methotrexate → Cimzia over 18 months. Notes unusual work-related stress factors but good adherence. Recommends continued biweekly self-injections with quarterly monitoring.",
      "metadata": {
        "format": "provider_report"
      }
    },
    {
      "id": "cluster_3_doc5",
      "content": "Regional research brief: Rheumatoid arthritis cases in Pacific Northwest show 22% increase among 40-55yo creatives since 2020. Study correlates with work-from-home ergonomic factors. Data suggests earlier biologics use improves long-term outcomes in this subgroup.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_3_doc6",
      "content": "Tacoma Tribune health section reports on local biologic medication access challenges. Mentions 3-month wait times at specialty pharmacies, particularly affecting autoimmune patients. Hospital system cites supply chain issues and increased demand since new insurance policies took effect.",
      "metadata": {
        "format": "news_article"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_3",
    "cluster_risk": "LOW",
    "content_summary": "Middle-aged creative professional's rheumatoid arthritis treatment journey intersecting with regional policy changes and demographic trends",
    "person": {
      "entities": [
        [
          "PlatinumPlus Plan",
          "NON_PERSONAL_ID"
        ],
        [
          "Tacoma, WA",
          "LOCATION"
        ],
        [
          "48",
          "AGE"
        ],
        [
          "freelance graphic designer",
          "UNIQUE_FACT"
        ],
        [
          "rheumatoid arthritis",
          "MEDICAL_CONDITION"
        ],
        [
          "methotrexate",
          "TREATMENT"
        ],
        [
          "Cimzia",
          "TREATMENT"
        ],
        [
          "Tacoma Arthritis Center",
          "PROVIDER"
        ]
      ]
    },
    "questions": [
      {
        "q": "Which biologic medication was prescribed to the freelance graphic designer in Tacoma after methotrexate?",
        "a": "Cimzia was prescribed following methotrexate treatment.",
        "sources": [
          "cluster_3_doc1"
        ],
        "type": "specific"
      },
      {
        "q": "What policy change in November 2023 affected coverage for biologic drugs in the Northwest region?",
        "a": "Prior genetic testing became required for biologic medications.",
        "sources": [
          "cluster_3_doc3"
        ],
        "type": "general"
      },
      {
        "q": "What two treatments did the Tacoma patient with rheumatoid arthritis receive before escalating to biologics?",
        "a": "The patient received NSAIDs followed by methotrexate.",
        "sources": [
          "cluster_3_doc2",
          "cluster_3_doc4"
        ],
        "type": "specific"
      },
      {
        "q": "Which demographic showed the highest increase in rheumatoid arthritis diagnoses according to recent research in the Pacific Northwest?",
        "a": "Creative professionals aged 40-55 showed a 22% increase.",
        "sources": [
          "cluster_3_doc5",
          "cluster_3_doc6"
        ],
        "type": "general"
      }
    ]
  }
}